Navigation Links
Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
Date:5/11/2010

='External Link';s.eVar3=s.prop5;s.prop15='93400739';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.harbingerresearch.com/link/13/253/CNBI">http://www.harbingerresearch.com/link/13/253/CNBI

About China Baicaotang Medicine, Ltd.

China Baicaotang is a vertically-integrated pharmaceutical company that operates in the Guangxi Province of China. The Company's three operating subsidiaries include a drug and herbal remedy manufacturing company, a pharmaceutical distributor that carries over 8,000 products, and a retail drugstore chain with 66 stores throughout the Guangxi province. The company is an emerging leader in this region of the PRC, and its shares currently traded on the OTC:BB under the symbol CNBI. Learn more http://www.china-bct.com .

About Harbinger Research, LLC

Harbinger Research is an independent equity research that employs a research team consisting entirely of CFA charter holders and follows a number of companies across a wide variety of industries. Harbinger Research makes all of its reports available through its website at http://www.harbingerresearch.com , and also distributes content through a variety of partners, including InvestorsInsight Publishing, and through most major financial portals.

Safe Harbor Statement<
'/>"/>

SOURCE China Baicaotang Medicine Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery
2. Orexigen(R) Therapeutics to Speak at Ninth Annual JMP Securities Research Conference
3. Silence Therapeutics Appoints New Vice President of Research
4. UCLA researchers use new microscope to see atoms for first time
5. TB Alliance and AstraZeneca Form Research Collaboration to Fight Tuberculosis
6. Knome Announces KnomeDISCOVERY Research Awards Program
7. The New York Stem Cell Foundation and The Johns Hopkins University School of Medicine to Collaborate on Stem Cell Research
8. Web-Based Management Suite Supports Complex Research Consortia
9. German MedSys Project Adopts Genedata Phylosopher for Research Informatics
10. New technique reinforces immune cells that seek and destroy cancer, says Stanford researcher
11. Materials research advances reliability of faster smart sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... focused on advanced wound care, announces that AMNIOEXCEL® ... have been added to the Premier, Inc. Regenerative ... opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 Earlier ... James L. Sherley, director of the Adult Stem Cell Technology ... overlooked and under appreciated unique property of adult tissue stem ... Misunderstood in the Past, Important for the Future,” embodied the ...
(Date:12/24/2014)... December 23, 2014 The report ... its definition, classification, application and industry overview. This ... product cost structure. Production is separated by regions, ... raw materials, equipment, downstream client survey, marketing channels, ...
Breaking Biology Technology:Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... DNDN ) today announced the following data presentations ... Meeting in Chicago, as well as a Dendreon-sponsored IMPACT ... April 28, 2009, ... phase III trial of sipuleucel-T in men with metastatic, ...
... - Strong Product Offerings and ... Nucletron, a global leader in radiation oncology, ... of EUR112.4 million (US $165,million). EBITDA in 2008 ended ... million with a strong fourth quarter contributing significantly to,the ...
... published their assembly of the domestic cow ( Bos ... community. The new version of the cow genome improves ... and accuracy. The article describing their research is freely ... Biology . , The research team led by Steven ...
Cached Biology Technology:Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting 2Nucletron Announces 2008 Results 2New cow genome sequence released 2
(Date:12/17/2014)... 16, 2014  Automation is fundamentally transforming the travel experience ... borders. Over the past decade, ePassports, biometric readers, and ... process through border control via eGates and Automated Passport ... seaports, and land borders across the globe. ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist Medical ... for its School of Medicine. Funding for this $50 million ... will be publicly launched next summer. The ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Yale is a founding member of the Genome-Wide RNAi ... centers formed to speed scientific and medical discoveries that ... is sponsored by Dharmacon, Inc. , manufacturer of ... of short, interfering ribonucleic acid sequences. The library is ...
... provide some of the most compelling evidence yet that ... standards--causes heart disease. Previous studies have linked air pollution ... understood how pollution damaged the body's blood vessels. , ... as polluted as the air in New York City, ...
... a swordtail fish, that is. As the size and ... preference for males with asymmetrical markings, according to a ... of biological sciences, and colleagues found that older female ... symmetrical males when offered a choice. These findings are ...
Cached Biology News:Yale participates in global human genome initiative 2Researchers show how air pollution can cause heart disease 2Researchers show how air pollution can cause heart disease 3Older female fish prefer imperfect male mates, study finds 2Older female fish prefer imperfect male mates, study finds 3
Request Info...
RABBIT ANTI TRANSFERRIN RECEPTOR...
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
RABBIT ANTI HUMAN ATR (aa2122-2380) Immunogen: Human ATR peptide, amino acids 2122-2380...
Biology Products: